284 related articles for article (PubMed ID: 28940225)
21. Management of ascites and hepatorenal syndrome.
Piano S; Tonon M; Angeli P
Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
[TBL] [Abstract][Full Text] [Related]
22. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
Wang SZ; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
[TBL] [Abstract][Full Text] [Related]
23. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.
Lebrec D; Giuily N; Hadengue A; Vilgrain V; Moreau R; Poynard T; Gadano A; Lassen C; Benhamou JP; Erlinger S
J Hepatol; 1996 Aug; 25(2):135-44. PubMed ID: 8878773
[TBL] [Abstract][Full Text] [Related]
24. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
25. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
[TBL] [Abstract][Full Text] [Related]
26. Management of refractory ascites.
Cárdenas A; Ginès P
Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1187-91. PubMed ID: 16361042
[No Abstract] [Full Text] [Related]
27. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
Ainsworth MA; Nielsen OH
Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
[No Abstract] [Full Text] [Related]
28. Management of Severe and Refractory Ascites.
Larrue H; Vinel JP; Bureau C
Clin Liver Dis; 2021 May; 25(2):431-440. PubMed ID: 33838859
[TBL] [Abstract][Full Text] [Related]
29. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
Garcia-Tsao G
Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501
[TBL] [Abstract][Full Text] [Related]
30. Feasibility and Procedural Safety of alfapump System Implantation by IR: Experience from the MOSAIC Study, a Multicenter, Open-Label Prospective Study in Cirrhotic Patients with Refractory Ascites.
Bendel EC; Sniderman K; Shaw C; Frederick RT; Wong F; Sanyal A; Asrani SK; Kamath PS; Capel J; Haskal ZJ
J Vasc Interv Radiol; 2020 Aug; 31(8):1256-1262.e3. PubMed ID: 32654961
[TBL] [Abstract][Full Text] [Related]
31. Management of ascites in cirrhosis.
Sandhu BS; Sanyal AJ
Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
[TBL] [Abstract][Full Text] [Related]
32. Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites.
Tergast TL; Griemsmann M; Stockhoff L; Port K; Heidrich B; Cornberg M; Wedemeyer H; Lenzen H; Richter N; Jaeckel E; Maasoumy B
JAMA Netw Open; 2023 Jul; 6(7):e2322048. PubMed ID: 37410459
[TBL] [Abstract][Full Text] [Related]
33. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.
Gaba RC; Parvinian A; Casadaban LC; Couture PM; Zivin SP; Lakhoo J; Minocha J; Ray CE; Knuttinen MG; Bui JT
Clin Radiol; 2015 May; 70(5):e51-7. PubMed ID: 25758602
[TBL] [Abstract][Full Text] [Related]
34. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
[TBL] [Abstract][Full Text] [Related]
35. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.
Stepanova M; Nader F; Bureau C; Adebayo D; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rossi S; MacDonald S; Capel J; Jalan R; Younossi ZM
Qual Life Res; 2018 Jun; 27(6):1513-1520. PubMed ID: 29460201
[TBL] [Abstract][Full Text] [Related]
36. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
[TBL] [Abstract][Full Text] [Related]
37. Refractory Ascites in Liver Cirrhosis.
Adebayo D; Neong SF; Wong F
Am J Gastroenterol; 2019 Jan; 114(1):40-47. PubMed ID: 29973706
[TBL] [Abstract][Full Text] [Related]
38. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
[TBL] [Abstract][Full Text] [Related]
39. Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study.
Bellot P; Welker MW; Soriano G; von Schaewen M; Appenrodt B; Wiest R; Whittaker S; Tzonev R; Handshiev S; Verslype C; Moench C; Zeuzem S; Sauerbruch T; Guarner C; Schott E; Johnson N; Petrov A; Katzarov K; Nevens F; Zapater P; Such J
J Hepatol; 2013 May; 58(5):922-7. PubMed ID: 23318604
[TBL] [Abstract][Full Text] [Related]
40. Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites.
Stirnimann G; Banz V; Storni F; De Gottardi A
Therap Adv Gastroenterol; 2017 Feb; 10(2):283-292. PubMed ID: 28203285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
